These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16339792)

  • 1. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
    Yamazaki H; Sasaki T
    J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice.
    Kawana F; Sasaki T
    J Electron Microsc (Tokyo); 2003; 52(6):515-25. PubMed ID: 14756239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
    Sasaki T
    Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
    Oshiro T; Shiotani A; Shibasaki Y; Sasaki T
    Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast differentiation at growth plate cartilage-trabecular bone junction in newborn rat femur.
    Sawae Y; Sahara T; Sasaki T
    J Electron Microsc (Tokyo); 2003; 52(6):493-502. PubMed ID: 14756237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.
    Romas E; Sims NA; Hards DK; Lindsay M; Quinn JW; Ryan PF; Dunstan CR; Martin TJ; Gillespie MT
    Am J Pathol; 2002 Oct; 161(4):1419-27. PubMed ID: 12368214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse.
    Gruber HE; Rude RK
    Biotech Histochem; 2003 Oct; 78(5):231-6. PubMed ID: 14989640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
    Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
    Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
    J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function.
    Shimizu-Ishiura M; Kawana F; Sasaki T
    J Electron Microsc (Tokyo); 2002; 51(5):315-25. PubMed ID: 12455916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression.
    Kobayashi Y; Hashimoto F; Miyamoto H; Kanaoka K; Miyazaki-Kawashita Y; Nakashima T; Shibata M; Kobayashi K; Kato Y; Sakai H
    J Bone Miner Res; 2000 Oct; 15(10):1924-34. PubMed ID: 11028444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
    Salmon P
    J Bone Miner Res; 2004 May; 19(5):695-702. PubMed ID: 15068491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone.
    Wang B; Jin H; Shu B; Mira RR; Chen D
    Sci Rep; 2015 Sep; 5():13667. PubMed ID: 26329493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation.
    Robertson KM; Norgård M; Windahl SH; Hultenby K; Ohlsson C; Andersson G; Gustafsson JA
    J Bone Miner Res; 2006 Aug; 21(8):1276-87. PubMed ID: 16869726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of beta catenin in hypertrophic growth plate chondrocytes impairs trabecular bone formation.
    Golovchenko S; Hattori T; Hartmann C; Gebhardt M; Gebhard S; Hess A; Pausch F; Schlund B; von der Mark K
    Bone; 2013 Jul; 55(1):102-12. PubMed ID: 23567158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.
    Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N
    Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective bone remodelling in osteoprotegerin-deficient mice.
    Amizuka N; Shimomura J; Li M; Seki Y; Oda K; Henderson JE; Mizuno A; Ozawa H; Maeda T
    J Electron Microsc (Tokyo); 2003; 52(6):503-13. PubMed ID: 14756238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
    Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
    J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.